Found 11 results
Author Title Type [ Year(Desc)]
Filters: Author is Horowitz, MM  [Clear All Filters]
2008
G. Laport, Bredeson, C., Tomblyn, M. R., Kahl, B. S., Goodman, S. A., Ewell, M., Klein, J., Horowitz, M. M., Vose, J. M., and Negrin, R. S., “Autologous vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Follicular Non-Hodgkins Lymphoma (FL) Beyond First Complete Response or First Partial Response”, in American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2008.
2011
R. Spellecy, Denzen, E. M., Santibáñez, M. E. Burton, Moore, H., Foley, A., Gersten, I. D., Gurgol, C., Horowitz, M. M., Majhail, N. S., and Murphy, E. A., “Informed Consent: Improving the Form and the Process”, in PRIM&R: Public Responsibility in Medicine and Research, National Harbor, MD, 2011.
2012
E. M. Denzen, Santibañez, M. E. B., Moore, H., Foley, A., Gersten, I. D., Gurgol, C., Majhail, N. S., Spellecy, R., Horowitz, M. M., and Murphy, E. A., “Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplant Clinical Trials”, Biol Blood Marrow Transplant, vol. 18, pp. 183-189, 2012.
J. Tolar, Deeg, H. J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., “Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels”, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W., Pasquini, M., MacMillan, M., Wingard, J., Waller, E., Grupp, S., McCarthy, P., Wu, J., Hu, Z., Carter, S., Horowitz, M. M., and Antin, J. H., “Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
2014
P. B. Jacobsen, Le-Rademacher, J., Jim, H., Syrjala, K., ,, Logan, B., Wu, J., Majhail, N. S., Wood, W., Rizzo, J. D., Geller, N. L., Kitko, C., Faber, E., Abidi, M. H., Slater, S., Horowitz, M. M., and Lee, S. J., “Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902”, Biol Blood Marrow Transplant, vol. 20, pp. 1530-1536, 2014.
W. Saber, Le Rademacher, J., Sekeres, M., Logan, B., Lewis, M., Mendizabal, A., Leifer, E., Appelbaum, F. R., Horowitz, M. M., Nakamura, R., and Cutler, C. S., “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*”, Biol Blood Marrow Transplant, vol. 20, pp. 1566-1572, 2014.
J. Bolanos-Meade, Logan, B. R., Alousi, A. M., Antin, J. H., Barowski, K., Carter, S. L., Goldstein, S. C., Hexner, E. O., Horowitz, M. M., Lee, S. J., Levine, J. E., MacMillan, M. L., Martin, P. J., Mendizabal, A. M., Nakamura, R., Pasquini, M. C., Weisdorf, D. J., Westervelt, P., and Ho, V. T., “Phase 3 Clinical trial of Steroids/Mycophenolate Mofetil vs Steroids/Placebo as Therapy for Acute GVHD: BMT CTN 0802”, Blood, vol. 124, pp. 3221-3227, 2014.
G. A. Yanik, Horowitz, M. M., Weisdorf, D. J., Logan, B. R., Ho, V. T., Soiffer, R. J., Carter, S. L., Wu, J., ,, Difronzo, N. L., Ferrara, J. L., Giralt, S., Madtes, D. K., Drexler, R., White, E. S., and Cooke, K. R., “Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol”, Biol Blood Marrow Transplant, vol. 20, pp. 858-864, 2014.
A. Howard, Fernandez-Vina, M. A., Appelbaum, F. R., Confer, D. L., Devine, S. M., Horowitz, M. M., Mendizabal, A., Laport, G. G., Pasquini, M. C., and , “Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)”, Biol Blood Marrow Transplant, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., “Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT”, Blood, vol. 124, pp. 1372-1377, 2014.